4//SEC Filing
Mulligan Seamus 4
Accession 0001765581-20-000055
CIK 0001232524other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 6:36 PM ET
Size
12.5 KB
Accession
0001765581-20-000055
Insider Transaction Report
Form 4
Mulligan Seamus
Director
Transactions
- Purchase
Ordinary Shares
2020-05-26$110.65/sh+15,000$1,659,747→ 1,117,788 total - Purchase
Ordinary Shares
2020-05-27$110.52/sh+8,391$927,352→ 1,131,422 total - Purchase
Ordinary Shares
2020-05-27$112.32/sh+11,482$1,289,646→ 1,152,788 total - Purchase
Ordinary Shares
2020-05-27$109.55/sh+5,243$574,379→ 1,123,031 total - Purchase
Ordinary Shares
2020-05-27$111.56/sh+9,884$1,102,682→ 1,141,306 total
Footnotes (5)
- [F1]Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $110.1800 to $110.9800. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.
- [F2]Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $109.0300 to $110.0200. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.
- [F3]Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from 110.0300 to $111.0100. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.
- [F4]Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $111.0350 to $112.0200. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.
- [F5]Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $112.0500 to $112.6600. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001536639
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 6:36 PM ET
- Size
- 12.5 KB